Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

Winston, A.; Stohr, W.; Antinori, A.; Arenas-Pinto, A.; Llibre, J.M.; Amieva, H.; Cabie, A.; Williams, I.; Di Perri, G.; Tellez, M.J.; Rockstroh, J.; Babiker, A.; Pozniak, A.; Raffi, F.; Richert, L.; Dedes, N.; Chene, G.; Allavena, C.; Autran, B.; Bucciardini, R.; Vella, S.; Horban, A.; Arribas, J.; Boffito, M.; Pillay, D.; Franquet, X.; Schwarze, S.; Grarup, J.; Fischer, A.; Wallet, C.; Diallo, A.; Molina, J.-.; Saillard, J.; Moecklinghoff, C.; Stellbrink, H.-.; Leeuwen, R.; Gatell, J.; Sandstrom, E.; Flepp, M.; Ewings, F.; George, E.C.; Hudson, F.; Pearce, G.; Quercia, R.; Rogatto, F.; Leavitt, R.; Nguyen, B.-.; Goebel, F.; Marcotullio, S.; Kaur, N.; Sasieni, P.; Spencer-Drake, C.; Peto, T.; Miller, V.; Chene, G.; Arnault, F.; Boucherie, C.; Fischer, A.; Jean, D.; Paniego, V.; Rouch, E.; Schwimmer, C.; Soussi, M.; Taieb, A.; Termote, M.; Touzeau, G.; Wallet, C.; Cursley, A.; Dodds, W.; Hoppe, A.; Kummeling, I.; Pacciarini, F.; Paton, N.; Russell, C.; Taylor, K.; Ward, D.; Aagaard, B.; Eid, M.; Gey, D.; Jensen, B.; Jakobsen, M.-.; Jansson, P.O.; Jensen, K.; Joensen, Z.; Larsen, E.; Pahl, C.; Pearson, M.; Nielsen, B.; Reilev, S.; Christ, I.; Lathouwers, D.; Manting, C.; Mendy, B.; Metro, A.; Couffin-Cadiergues, S.; Knellwolf, A.-.; Palmisiano, L.; Aznar, E.; Barea, C.; Cotarelo, M.; Esteban, H.; Girbau, I.; Moyano, B.; Ramirez, M.; Saiz, C.; Sanchez, I.; Yllescas, M.; Binelli, A.; Colasanti, V.; Massella, M.; Anagnostou, O.; Gioukari, V.; Touloumi, G.; Schmied, B.; Rieger, A.; Vetter, N.; Wit, S.; Florence, E.; Vandekerckhove, L.; Gerstoft, J.; Mathiesen, L.; Katlama, C.; Cabie, A.; Cheret, A.; Dupon, M.; Ghosn, J.; Girard, P.-.; Goujard, C.; Levy, Y.; Morlat, P.; Neau, D.; Obadia, M.; Perre, P.; Piroth, L.; Reynes, J.; Tattevin, P.; Ragnaud, J.; Weiss, L.; Yazdan, Y.; Yeni, P.; Zucman, D.; Behrens, G.; Esser, S.; Fatkenheuer, G.; Hoffmann, C.; Jessen, H.; Schmidt, R.; Stephan, C.; Unger, S.; Hatzakis, A.; Daikos, G.L.; Papadopoulos, A.; Skoutelis, A.; Banhegyi, D.; Mallon, P.; Mulcahy, F.; Andreoni, M.; Bonora, S.; Castelli, F.; Monforte, A.; Galli, M.; Lazzarin, A.; Mazzotta, F.; Carlo, T.; Vullo, V.; Prins, J.; Richter, C.; Verhagen, D.; Eeden, A.; Doroana, M.; Antunes, F.; Maltez, F.; Sarmento-Castro, R.; Garcia, J.; Aldeguer, J.; Clotet, B.; Domingo, P.; Gatell, J.M.; Knobel, H.; Marquez, M.; Miralles, M.; Portilla, J.; Soriano, V.; Thalme, A.; Blaxhult, A.; Gisslen, M.; Fox, J.; Gompels, M.; Herieka, E.; Johnson, M.; Leen, C.; Teague, A.; Boyd, M.; Moller, N.; Frosig, E.; Moing, V.; Wit, F.W.N.M.; Kowalska, J.; Berenguer, J.; Moreno, S.; Muhller, N.J.; Torok, E.; Post, F.; Angus, B.; Calvez, V.; Boucher, C.; Collins, S.; Dunn, D.; Lambert, S.; Marcelin, A.-.; Perno, C.; White, E.; Ammassari, A.; Stoehr, W.; Schmidt, R.; Odermarsky, M.; Smith, C.; Thiebaut, R.; Laserna, B.; Castagna, A.; Furrer, H.-.; Mocroft, A.; Reiss, P.; Fragola, V.; Lauriola, M.; Murri, R.; Nieuwkerk, P.; Spire, B.; Volny-Anne, A.; West, B.; Maria, J.; Braggion, M.; Foca, E.

doi:10.1111/hiv.12344

Objectives: Deficits in cognitive function remain prevalent in HIV-infected individuals. The aim of this European multicentre study was to assess factors associated with cognitive function in antiretroviral therapy (ART)-naïve HIV-infected subjects at the time of enrolment in the NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 study. Methods: Prior to starting ART, seven cognitive tests exploring domains including episodic memory, verbal fluency, executive function and psychomotor speed were administered with scores standardized to z-score using the study population sample mean and standard deviation. The primary measure was overall z-score average (NPZ). We assessed associations between baseline factors and test results using multivariable regression models. Results: Of 283 subjects with baseline cognitive assessments, 90% were male and 12% of black ethnicity. Median (interquartile range) age, years of education, years of known HIV infection, baseline CD4 count and baseline HIV RNA were 39 (31, 47) years, 13 (11, 17) years, 1 (0, 4) years, 344 (279, 410) cells/μL and 4.74 (4.28, 5.14) log10 HIV-1 RNA copies/mL, respectively. Forty per cent were current smokers. Factors significantly associated with poorer overall cognitive performance in multivariable models included older age, shorter duration of education, black ethnicity, lower height, and lower plasma HIV RNA. Conclusions: In this large, European-wide, ART-naïve population with relatively preserved immunity and early HIV infection, cognitive function scores at the time of ART initiation were associated with demographic and HIV-disease factors.

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy / A. Winston, W. Stohr, A. Antinori, A. Arenas-Pinto, J.M. Llibre, H. Amieva, A. Cabie, I. Williams, G. Di Perri, M.J. Tellez, J. Rockstroh, A. Babiker, A. Pozniak, F. Raffi, L. Richert, N. Dedes, G. Chene, C. Allavena, B. Autran, R. Bucciardini, S. Vella, A. Horban, J. Arribas, M. Boffito, D. Pillay, X. Franquet, S. Schwarze, J. Grarup, A. Fischer, C. Wallet, A. Diallo, J.-. Molina, J. Saillard, C. Moecklinghoff, H.-. Stellbrink, R. Leeuwen, J. Gatell, E. Sandstrom, M. Flepp, F. Ewings, E.C. George, F. Hudson, G. Pearce, R. Quercia, F. Rogatto, R. Leavitt, B.-. Nguyen, F. Goebel, S. Marcotullio, N. Kaur, P. Sasieni, C. Spencer-Drake, T. Peto, V. Miller, G. Chene, F. Arnault, C. Boucherie, A. Fischer, D. Jean, V. Paniego, E. Rouch, C. Schwimmer, M. Soussi, A. Taieb, M. Termote, G. Touzeau, C. Wallet, A. Cursley, W. Dodds, A. Hoppe, I. Kummeling, F. Pacciarini, N. Paton, C. Russell, K. Taylor, D. Ward, B. Aagaard, M. Eid, D. Gey, B. Jensen, M.-. Jakobsen, P.O. Jansson, K. Jensen, Z. Joensen, E. Larsen, C. Pahl, M. Pearson, B. Nielsen, S. Reilev, I. Christ, D. Lathouwers, C. Manting, B. Mendy, A. Metro, S. Couffin-Cadiergues, A.-. Knellwolf, L. Palmisiano, E. Aznar, C. Barea, M. Cotarelo, H. Esteban, I. Girbau, B. Moyano, M. Ramirez, C. Saiz, I. Sanchez, M. Yllescas, A. Binelli, V. Colasanti, M. Massella, O. Anagnostou, V. Gioukari, G. Touloumi, B. Schmied, A. Rieger, N. Vetter, S. Wit, E. Florence, L. Vandekerckhove, J. Gerstoft, L. Mathiesen, C. Katlama, A. Cabie, A. Cheret, M. Dupon, J. Ghosn, P.-. Girard, C. Goujard, Y. Levy, P. Morlat, D. Neau, M. Obadia, P. Perre, L. Piroth, J. Reynes, P. Tattevin, J. Ragnaud, L. Weiss, Y. Yazdan, P. Yeni, D. Zucman, G. Behrens, S. Esser, G. Fatkenheuer, C. Hoffmann, H. Jessen, R. Schmidt, C. Stephan, S. Unger, A. Hatzakis, G.L. Daikos, A. Papadopoulos, A. Skoutelis, D. Banhegyi, P. Mallon, F. Mulcahy, M. Andreoni, S. Bonora, F. Castelli, A. Monforte, M. Galli, A. Lazzarin, F. Mazzotta, T. Carlo, V. Vullo, J. Prins, C. Richter, D. Verhagen, A. Eeden, M. Doroana, F. Antunes, F. Maltez, R. Sarmento-Castro, J. Garcia, J. Aldeguer, B. Clotet, P. Domingo, J.M. Gatell, H. Knobel, M. Marquez, M. Miralles, J. Portilla, V. Soriano, A. Thalme, A. Blaxhult, M. Gisslen, J. Fox, M. Gompels, E. Herieka, M. Johnson, C. Leen, A. Teague, M. Boyd, N. Moller, E. Frosig, V. Moing, F.W.N.M. Wit, J. Kowalska, J. Berenguer, S. Moreno, N.J. MuHller, E. Torok, F. Post, B. Angus, V. Calvez, C. Boucher, S. Collins, D. Dunn, S. Lambert, A.-. Marcelin, C. Perno, E. White, A. Ammassari, W. Stoehr, R. Schmidt, M. Odermarsky, C. Smith, R. Thiebaut, B. LaSerna, A. Castagna, H.-. Furrer, A. Mocroft, P. Reiss, V. Fragola, M. Lauriola, R. Murri, P. Nieuwkerk, B. Spire, A. Volny-Anne, B. West, J. Maria, M. Braggion, E. Foca. - In: HIV MEDICINE. - ISSN 1464-2662. - 17:6(2016 Jun), pp. 471-478.

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

Winston A.;Stohr W.;Antinori A.;Arenas-Pinto A.;Llibre J. M.;Amieva H.;Cabie A.;Williams I.;Di Perri G.;Tellez M. J.;Rockstroh J.;Babiker A.;Pozniak A.;Raffi F.;Richert L.;Dedes N.;Chene G.;Allavena C.;Autran B.;Bucciardini R.;Vella S.;Horban A.;Arribas J.;Boffito M.;Pillay D.;Franquet X.;Schwarze S.;Grarup J.;Fischer A.;Wallet C.;Diallo A.;Molina J. -M.;Saillard J.;Moecklinghoff C.;Stellbrink H. -J.;Leeuwen R.;Gatell J.;Sandstrom E.;Flepp M.;Ewings F.;George E. C.;Hudson F.;Pearce G.;Quercia R.;Rogatto F.;Leavitt R.;Nguyen B. -Y.;Goebel F.;Marcotullio S.;Kaur N.;Sasieni P.;Spencer-Drake C.;Peto T.;Miller V.;Chene G.;Arnault F.;Boucherie C.;Fischer A.;Jean D.;Paniego V.;Rouch E.;Schwimmer C.;Soussi M.;Taieb A.;Termote M.;Touzeau G.;Wallet C.;Cursley A.;Dodds W.;Hoppe A.;Kummeling I.;Pacciarini F.;Paton N.;Russell C.;Taylor K.;Ward D.;Aagaard B.;Eid M.;Gey D.;Jensen B.;Jakobsen M. -L.;Jansson P. O.;Jensen K.;Joensen Z.;Larsen E.;Pahl C.;Pearson M.;Nielsen B.;Reilev S.;Christ I.;Lathouwers D.;Manting C.;Mendy B.;Metro A.;Couffin-Cadiergues S.;Knellwolf A. -L.;Palmisiano L.;Aznar E.;Barea C.;Cotarelo M.;Esteban H.;Girbau I.;Moyano B.;Ramirez M.;Saiz C.;Sanchez I.;Yllescas M.;Binelli A.;Colasanti V.;Massella M.;Anagnostou O.;Gioukari V.;Touloumi G.;Schmied B.;Rieger A.;Vetter N.;Wit S.;Florence E.;Vandekerckhove L.;Gerstoft J.;Mathiesen L.;Katlama C.;Cabie A.;Cheret A.;Dupon M.;Ghosn J.;Girard P. -M.;Goujard C.;Levy Y.;Morlat P.;Neau D.;Obadia M.;Perre P.;Piroth L.;Reynes J.;Tattevin P.;Ragnaud J.;Weiss L.;Yazdan Y.;Yeni P.;Zucman D.;Behrens G.;Esser S.;Fatkenheuer G.;Hoffmann C.;Jessen H.;Schmidt R.;Stephan C.;Unger S.;Hatzakis A.;Daikos G. L.;Papadopoulos A.;Skoutelis A.;Banhegyi D.;Mallon P.;Mulcahy F.;Andreoni M.;S. Bonora;Castelli F.;Monforte A.;M. Galli;A. Lazzarin;Mazzotta F.;Carlo T.;Vullo V.;Prins J.;Richter C.;Verhagen D.;Eeden A.;Doroana M.;Antunes F.;Maltez F.;Sarmento-Castro R.;Garcia J.;Aldeguer J.;Clotet B.;Domingo P.;Gatell J. M.;Knobel H.;Marquez M.;Miralles M.;Portilla J.;Soriano V.;Thalme A.;Blaxhult A.;Gisslen M.;Fox J.;Gompels M.;Herieka E.;Johnson M.;Leen C.;Teague A.;Boyd M.;Moller N.;Frosig E.;Moing V.;Wit F. W. N. M.;Kowalska J.;Berenguer J.;Moreno S.;MuHller N. J.;Torok E.;Post F.;Angus B.;Calvez V.;Boucher C.;Collins S.;Dunn D.;Lambert S.;Marcelin A. -G.;C. Perno;White E.;Ammassari A.;Stoehr W.;Schmidt R.;Odermarsky M.;Smith C.;Thiebaut R.;LaSerna B.;Castagna A.;Furrer H. -J.;Mocroft A.;Reiss P.;Fragola V.;Lauriola M.;Murri R.;Nieuwkerk P.;Spire B.;Volny-Anne A.;West B.;Maria J.;Braggion M.;Foca E.

2016

Abstract

Objectives: Deficits in cognitive function remain prevalent in HIV-infected individuals. The aim of this European multicentre study was to assess factors associated with cognitive function in antiretroviral therapy (ART)-naïve HIV-infected subjects at the time of enrolment in the NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 study. Methods: Prior to starting ART, seven cognitive tests exploring domains including episodic memory, verbal fluency, executive function and psychomotor speed were administered with scores standardized to z-score using the study population sample mean and standard deviation. The primary measure was overall z-score average (NPZ). We assessed associations between baseline factors and test results using multivariable regression models. Results: Of 283 subjects with baseline cognitive assessments, 90% were male and 12% of black ethnicity. Median (interquartile range) age, years of education, years of known HIV infection, baseline CD4 count and baseline HIV RNA were 39 (31, 47) years, 13 (11, 17) years, 1 (0, 4) years, 344 (279, 410) cells/μL and 4.74 (4.28, 5.14) log10 HIV-1 RNA copies/mL, respectively. Forty per cent were current smokers. Factors significantly associated with poorer overall cognitive performance in multivariable models included older age, shorter duration of education, black ethnicity, lower height, and lower plasma HIV RNA. Conclusions: In this large, European-wide, ART-naïve population with relatively preserved immunity and early HIV infection, cognitive function scores at the time of ART initiation were associated with demographic and HIV-disease factors.

Scheda breve

Scheda completa

Scheda completa (DC)

	Parole chiave
	
			antiretroviral naïve; cognitive; HIV; neuropsychological tests; Adult; Anti-Retroviral Agents; Cognitive Dysfunction; Europe; Female; HIV Infections; Humans; Male; Middle Aged; Psychological Tests
		
	Settori scientifico-disciplinari dell'articolo
	
			Settore MED/07 - Microbiologia e Microbiologia Clinica
Settore MED/17 - Malattie Infettive
		
	Data di pubblicazione
	
			giu-2016
		
	Rivista in ANCE
	
			HIV MEDICINE
		
	DOI
	
			https://dx.doi.org/10.1111/hiv.12344
		
	Tipologia
	
			Article (author)
		
	Appare nelle tipologie:
	
			01 - Articolo su periodico

File in questo prodotto:

File	Dimensione	Formato
hiv.12344.pdf accesso aperto Tipologia: Publisher's version/PDF Dimensione 70.57 kB Formato Adobe PDF Visualizza/Apri	70.57 kB	Adobe PDF	Visualizza/Apri

Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/774146

Citazioni

3

7

5

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca